Don Tracy

1 week ago | appliedclinicaltrialsonline.com | Don Tracy

At the DIA Annual Meeting, Peter Ronco, CEO, Emmes, emphasized the under-recognized but impactful role of the public sector—particularly the NIH and FDA—in advancing tech-enabled clinical development. These agencies have pioneered the use of AI and large language models for tasks such as automating IND submissions, optimizing protocol design, and leveraging decades of complex data to improve trial execution and patient recruitment.

1 week ago | pharmaceuticalcommerce.com | Don Tracy

Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial SuccessIn an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer at Novotech, emphasized the value of trust-based CRO-sponsor relationships and celebrated the company’s Citeline CRO Partnership of the Year Award for its collaboration with Tune Therapeutics as a model of strategic, patient-centered clinical trial partnership.

1 week ago | appliedclinicaltrialsonline.com | Don Tracy

At the DIA Annual Meeting, Peter Ronco, CEO, Emmes, emphasized the underrecognized but impactful role of the public sector—particularly the NIH and FDA—in advancing tech-enabled clinical development. These agencies have pioneered the use of AI and large language models for tasks such as automating IND submissions, optimizing protocol design, and leveraging decades of complex data to improve trial execution and patient recruitment.

1 week ago | pharmaceuticalcommerce.com | Don Tracy

Strategic Planning in the Rebate Economy: What Pharma Must Do NowA recent Pharmaceutical Executive article outlines how, despite decades of evolving policy from OBRA ’90 to the Inflation Reduction Act, the US pharmaceutical system remains deeply reliant on manufacturer rebates—prompting drugmakers to shift from workaround tactics to strategic execution in order to thrive in today’s rebate-driven environment while preparing for a more transparent, reform-ready future.

1 week ago | appliedclinicaltrialsonline.com | Don Tracy

In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer, uMotif, discussed how the company actively incorporates patient and site feedback throughout the digital health product lifecycle to ensure its tools are both accessible and intuitive.